Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 271

1.

Activation of latent HIV-1 T cell reservoirs with a combination of innate immune and epigenetic regulators.

Palermo E, Acchioni C, Di Carlo D, Zevini A, Muscolini M, Ferrari M, Castiello L, Virtuoso S, Borsetti A, Antonelli G, Turriziani O, Sgarbanti M, Hiscott J.

J Virol. 2019 Aug 14. pii: JVI.01194-19. doi: 10.1128/JVI.01194-19. [Epub ahead of print]

PMID:
31413127
2.

Alternate NF-κB independent signaling re-activation of latent HIV-1 provirus.

Acchioni C, Remoli AL, Marsili G, Acchioni M, Nardolillo I, Orsatti R, Farcomeni S, Palermo E, Perrotti E, Barreca ML, Sabatini S, Sandini S, Parolin C, Lin R, Borsetti A, Hiscott J, Sgarbanti M.

J Virol. 2019 Jun 26. pii: JVI.00495-19. doi: 10.1128/JVI.00495-19. [Epub ahead of print]

PMID:
31243131
3.

SIRT1 Modulates the Sensitivity of Prostate Cancer Cells to Vesicular Stomatitis Virus Oncolysis.

Muscolini M, Castiello L, Palermo E, Zevini A, Ferrari M, Olagnier D, Hiscott J.

J Virol. 2019 Jul 17;93(15). pii: e00626-19. doi: 10.1128/JVI.00626-19. Print 2019 Aug 1.

PMID:
31092575
4.

Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting.

De Santis F, Del Vecchio M, Castagnoli L, De Braud F, Di Cosimo S, Franceschini D, Fucà G, Hiscott J, Malmberg KJ, McGranahan N, Pietrantonio F, Rivoltini L, Sangaletti S, Tagliabue E, Tripodo C, Vernieri C, Zitvogel L, Pupa SM, Di Nicola M.

Cytokine Growth Factor Rev. 2018 Dec;44:1-10. doi: 10.1016/j.cytogfr.2018.10.005. Epub 2018 Oct 30.

PMID:
30393044
5.

Cytokines 2017 in Kanazawa: Looking beyond the horizon of integrated cytokine research from the sea of Japan.

Olagnier D, Hiscott J.

Cytokine Growth Factor Rev. 2018 Feb 4. pii: S1359-6101(18)30011-X. doi: 10.1016/j.cytogfr.2018.01.008. [Epub ahead of print] Review.

PMID:
29428617
6.

Innovative Therapy, Monoclonal Antibodies and Beyond.

Di Nicola M, Apetoh L, Bellone M, Colombo MP, Dotti G, Ferrone S, Muscolini M, Hiscott J, Anichini A, Pupa SM, Braud F, Del Vecchio M.

Cytokine Growth Factor Rev. 2017 Dec;38:1-9. doi: 10.1016/j.cytogfr.2017.10.002. Epub 2017 Oct 5.

PMID:
29029813
7.

Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities.

Pelliccia S, Wu YH, Coluccia A, La Regina G, Tseng CK, Famiglini V, Masci D, Hiscott J, Lee JC, Silvestri R.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):1091-1101. doi: 10.1080/14756366.2017.1355791.

8.

Human Monocyte Subsets Are Transcriptionally and Functionally Altered in Aging in Response to Pattern Recognition Receptor Agonists.

Metcalf TU, Wilkinson PA, Cameron MJ, Ghneim K, Chiang C, Wertheimer AM, Hiscott JB, Nikolich-Zugich J, Haddad EK.

J Immunol. 2017 Aug 15;199(4):1405-1417. doi: 10.4049/jimmunol.1700148. Epub 2017 Jul 10.

9.

Sphingosine 1-Phosphate Lyase Enhances the Activation of IKKε To Promote Type I IFN-Mediated Innate Immune Responses to Influenza A Virus Infection.

Vijayan M, Xia C, Song YE, Ngo H, Studstill CJ, Drews K, Fox TE, Johnson MC, Hiscott J, Kester M, Alexander S, Hahm B.

J Immunol. 2017 Jul 15;199(2):677-687. doi: 10.4049/jimmunol.1601959. Epub 2017 Jun 9.

10.

Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity.

Olagnier D, Lababidi RR, Hadj SB, Sze A, Liu Y, Naidu SD, Ferrari M, Jiang Y, Chiang C, Beljanski V, Goulet ML, Knatko EV, Dinkova-Kostova AT, Hiscott J, Lin R.

Mol Ther. 2017 Aug 2;25(8):1900-1916. doi: 10.1016/j.ymthe.2017.04.022. Epub 2017 May 17.

11.

Crosstalk between Cytoplasmic RIG-I and STING Sensing Pathways.

Zevini A, Olagnier D, Hiscott J.

Trends Immunol. 2017 Mar;38(3):194-205. doi: 10.1016/j.it.2016.12.004. Epub 2017 Jan 7. Review.

12.

HIV-1 Tat Recruits HDM2 E3 Ligase To Target IRF-1 for Ubiquitination and Proteasomal Degradation.

Remoli AL, Marsili G, Perrotti E, Acchioni C, Sgarbanti M, Borsetti A, Hiscott J, Battistini A.

MBio. 2016 Oct 18;7(5). pii: e01528-16. doi: 10.1128/mBio.01528-16.

13.
14.

RAIDD Mediates TLR3 and IRF7 Driven Type I Interferon Production.

Maney SK, Xu HC, Huang J, Pandyra AA, Ehlting C, Aguilar-Valenzuela R, Pozdeev VI, McIlwain DR, Zimmermann A, Bode JG, Hengel H, Kirschning CJ, Kim IR, Hiscott J, Brenner D, Häussinger D, Ohashi PS, Mak TW, Lang KS, Lang PA.

Cell Physiol Biochem. 2016;39(4):1271-80. doi: 10.1159/000447832. Epub 2016 Sep 8.

15.

Mechanisms of Zika Virus Infection and Neuropathogenesis.

Olagnier D, Muscolini M, Coyne CB, Diamond MS, Hiscott J.

DNA Cell Biol. 2016 Aug;35(8):367-72. doi: 10.1089/dna.2016.3404. Epub 2016 Jun 27.

16.

Dengue Virus Immunopathogenesis: Lessons Applicable to the Emergence of Zika Virus.

Olagnier D, Amatore D, Castiello L, Ferrari M, Palermo E, Diamond MS, Palamara AT, Hiscott J.

J Mol Biol. 2016 Aug 28;428(17):3429-48. doi: 10.1016/j.jmb.2016.04.024. Epub 2016 Apr 27. Review.

PMID:
27130436
17.

Mouse superkiller-2-like helicase DDX60 is dispensable for type I IFN induction and immunity to multiple viruses.

Goubau D, van der Veen AG, Chakravarty P, Lin R, Rogers N, Rehwinkel J, Deddouche S, Rosewell I, Hiscott J, Reis e Sousa C.

Eur J Immunol. 2015 Dec;45(12):3386-403. doi: 10.1002/eji.201545794. Epub 2015 Oct 12.

18.

Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.

Pinto AK, Brien JD, Lam CY, Johnson S, Chiang C, Hiscott J, Sarathy VV, Barrett AD, Shresta S, Diamond MS.

MBio. 2015 Sep 15;6(5):e01316-15. doi: 10.1128/mBio.01316-15.

19.

Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.

Beljanski V, Chiang C, Kirchenbaum GA, Olagnier D, Bloom CE, Wong T, Haddad EK, Trautmann L, Ross TM, Hiscott J.

J Virol. 2015 Oct;89(20):10612-24. doi: 10.1128/JVI.01526-15. Epub 2015 Aug 12.

20.

Crosstalk between the TNF and IGF pathways enhances NF-κB activation and signaling in cancer cells.

Li S, Pinard M, Wang Y, Yang L, Lin R, Hiscott J, Su B, Brodt P.

Growth Horm IGF Res. 2015 Oct;25(5):253-61. doi: 10.1016/j.ghir.2015.07.008. Epub 2015 Jul 20.

PMID:
26239406
21.

The intersection between viral oncolysis, drug resistance, and autophagy.

Beljanski V, Chiang C, Hiscott J.

Biol Chem. 2015 Dec;396(12):1269-80. doi: 10.1515/hsz-2015-0147. Review.

PMID:
26068902
22.

Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists.

Chiang C, Beljanski V, Yin K, Olagnier D, Ben Yebdri F, Steel C, Goulet ML, DeFilippis VR, Streblow DN, Haddad EK, Trautmann L, Ross T, Lin R, Hiscott J.

J Virol. 2015 Aug;89(15):8011-25. doi: 10.1128/JVI.00845-15. Epub 2015 May 27.

23.

Aryl Hydrocarbon Receptor Interacting Protein Targets IRF7 to Suppress Antiviral Signaling and the Induction of Type I Interferon.

Zhou Q, Lavorgna A, Bowman M, Hiscott J, Harhaj EW.

J Biol Chem. 2015 Jun 5;290(23):14729-39. doi: 10.1074/jbc.M114.633065. Epub 2015 Apr 24.

24.

The TEL-AML1 fusion protein of acute lymphoblastic leukemia modulates IRF3 activity during early B-cell differentiation.

de Laurentiis A, Hiscott J, Alcalay M.

Oncogene. 2015 Dec 3;34(49):6018-28. doi: 10.1038/onc.2015.50. Epub 2015 Apr 20.

PMID:
25893288
25.

Paula Pitha-Rowe, PhD (1938-2015).

Hiscott J.

J Interferon Cytokine Res. 2015 May;35(5):325-6. doi: 10.1089/jir.2015.1501. Epub 2015 Apr 9. No abstract available.

PMID:
25856318
26.

Global analyses revealed age-related alterations in innate immune responses after stimulation of pathogen recognition receptors.

Metcalf TU, Cubas RA, Ghneim K, Cartwright MJ, Grevenynghe JV, Richner JM, Olagnier DP, Wilkinson PA, Cameron MJ, Park BS, Hiscott JB, Diamond MS, Wertheimer AM, Nikolich-Zugich J, Haddad EK.

Aging Cell. 2015 Jun;14(3):421-32. doi: 10.1111/acel.12320. Epub 2015 Feb 27.

27.

HTLV-1 Tax-mediated inhibition of FOXO3a activity is critical for the persistence of terminally differentiated CD4+ T cells.

Olagnier D, Sze A, Bel Hadj S, Chiang C, Steel C, Han X, Routy JP, Lin R, Hiscott J, van Grevenynghe J.

PLoS Pathog. 2014 Dec 18;10(12):e1004575. doi: 10.1371/journal.ppat.1004575. eCollection 2014 Dec.

28.

Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cells.

Olagnier D, Peri S, Steel C, van Montfoort N, Chiang C, Beljanski V, Slifker M, He Z, Nichols CN, Lin R, Balachandran S, Hiscott J.

PLoS Pathog. 2014 Dec 18;10(12):e1004566. doi: 10.1371/journal.ppat.1004566. eCollection 2014 Dec.

29.

Innate immune sensing of HIV-1 infection.

Jakobsen MR, Olagnier D, Hiscott J.

Curr Opin HIV AIDS. 2015 Mar;10(2):96-102. doi: 10.1097/COH.0000000000000129. Review.

PMID:
25485569
30.

Introduction to innate sensing and response to pathogens (part 2).

Hiscott J.

Cytokine Growth Factor Rev. 2014 Dec;25(6):629-30. doi: 10.1016/j.cytogfr.2014.11.001. Epub 2014 Nov 19. No abstract available.

PMID:
25458908
31.

Introduction to innate sensing and response to pathogens.

Hiscott J.

Cytokine Growth Factor Rev. 2014 Oct;25(5):489-90. doi: 10.1016/j.cytogfr.2014.09.004. Epub 2014 Oct 28. No abstract available.

PMID:
25443974
32.

Anti-viral tetris: modulation of the innate anti-viral immune response by A20.

Arguello M, Paz S, Ferran C, Moll HP, Hiscott J.

Adv Exp Med Biol. 2014;809:49-64. Review.

PMID:
25302365
33.

Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma.

Kreher S, Bouhlel MA, Cauchy P, Lamprecht B, Li S, Grau M, Hummel F, Köchert K, Anagnostopoulos I, Jöhrens K, Hummel M, Hiscott J, Wenzel SS, Lenz P, Schneider M, Küppers R, Scheidereit C, Giefing M, Siebert R, Rajewsky K, Lenz G, Cockerill PN, Janz M, Dörken B, Bonifer C, Mathas S.

Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4513-22. doi: 10.1073/pnas.1406985111. Epub 2014 Oct 6.

34.

Unmasking immune sensing of retroviruses: interplay between innate sensors and host effectors.

van Montfoort N, Olagnier D, Hiscott J.

Cytokine Growth Factor Rev. 2014 Dec;25(6):657-68. doi: 10.1016/j.cytogfr.2014.08.006. Epub 2014 Sep 3. Review.

PMID:
25240798
35.

Coxsackievirus cloverleaf RNA containing a 5' triphosphate triggers an antiviral response via RIG-I activation.

Feng Q, Langereis MA, Olagnier D, Chiang C, van de Winkel R, van Essen P, Zoll J, Hiscott J, van Kuppeveld FJ.

PLoS One. 2014 Apr 23;9(4):e95927. doi: 10.1371/journal.pone.0095927. eCollection 2014.

36.

Type I and type III interferon-induced immune response: it's a matter of kinetics and magnitude.

Olagnier D, Hiscott J.

Hepatology. 2014 Apr;59(4):1225-8. doi: 10.1002/hep.26959. Epub 2014 Feb 28. No abstract available.

PMID:
24677190
37.

Conference highlights of the 16th International Conference on Human Retrovirology: HTLV and related retroviruses, 26-30 June 2013, Montreal, Canada.

Barbeau B, Hiscott J, Bazarbachi A, Carvalho E, Jones K, Martin F, Matsuoka M, Murphy EL, Ratner L, Switzer WM, Watanabe T.

Retrovirology. 2014 Feb 24;11:19. doi: 10.1186/1742-4690-11-19.

38.

Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response.

Olagnier D, Scholte FE, Chiang C, Albulescu IC, Nichols C, He Z, Lin R, Snijder EJ, van Hemert MJ, Hiscott J.

J Virol. 2014 Apr;88(8):4180-94. doi: 10.1128/JVI.03114-13. Epub 2014 Jan 29.

39.

IκB kinase ε targets interferon regulatory factor 1 in activated T lymphocytes.

Sgarbanti M, Marsili G, Remoli AL, Stellacci E, Mai A, Rotili D, Perrotti E, Acchioni C, Orsatti R, Iraci N, Ferrari M, Borsetti A, Hiscott J, Battistini A.

Mol Cell Biol. 2014 Mar;34(6):1054-65. doi: 10.1128/MCB.01161-13. Epub 2014 Jan 6.

40.

Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagy.

Shulak L, Beljanski V, Chiang C, Dutta SM, Van Grevenynghe J, Belgnaoui SM, Nguyên TL, Di Lenardo T, Semmes OJ, Lin R, Hiscott J.

J Virol. 2014 Mar;88(5):2927-40. doi: 10.1128/JVI.03406-13. Epub 2013 Dec 26.

41.

SAMHD1 host restriction factor: a link with innate immune sensing of retrovirus infection.

Sze A, Olagnier D, Lin R, van Grevenynghe J, Hiscott J.

J Mol Biol. 2013 Dec 13;425(24):4981-94. doi: 10.1016/j.jmb.2013.10.022. Epub 2013 Oct 23. Review.

PMID:
24161438
42.

Host restriction factor SAMHD1 limits human T cell leukemia virus type 1 infection of monocytes via STING-mediated apoptosis.

Sze A, Belgnaoui SM, Olagnier D, Lin R, Hiscott J, van Grevenynghe J.

Cell Host Microbe. 2013 Oct 16;14(4):422-34. doi: 10.1016/j.chom.2013.09.009.

43.

Intact type I Interferon production and IRF7 function in sooty mangabeys.

Bosinger SE, Johnson ZP, Folkner KA, Patel N, Hashempour T, Jochems SP, Del Rio Estrada PM, Paiardini M, Lin R, Vanderford TH, Hiscott J, Silvestri G.

PLoS Pathog. 2013;9(8):e1003597. doi: 10.1371/journal.ppat.1003597. Epub 2013 Aug 29.

44.

Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis.

Ben Yebdri F, Van Grevenynghe J, Tang VA, Goulet ML, Wu JH, Stojdl DF, Hiscott J, Lin R.

Mol Ther. 2013 Nov;21(11):2043-53. doi: 10.1038/mt.2013.187. Epub 2013 Aug 28.

45.

BCL-2 inhibitors sensitize therapy-resistant chronic lymphocytic leukemia cells to VSV oncolysis.

Samuel S, Beljanski V, Van Grevenynghe J, Richards S, Ben Yebdri F, He Z, Nichols C, Belgnaoui SM, Steel C, Goulet ML, Shamy A, Brown D, Abesada G, Haddad EK, Hiscott J.

Mol Ther. 2013 Jul;21(7):1413-23. doi: 10.1038/mt.2013.91. Epub 2013 May 21.

46.

Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity.

Goulet ML, Olagnier D, Xu Z, Paz S, Belgnaoui SM, Lafferty EI, Janelle V, Arguello M, Paquet M, Ghneim K, Richards S, Smith A, Wilkinson P, Cameron M, Kalinke U, Qureshi S, Lamarre A, Haddad EK, Sekaly RP, Peri S, Balachandran S, Lin R, Hiscott J.

PLoS Pathog. 2013;9(4):e1003298. doi: 10.1371/journal.ppat.1003298. Epub 2013 Apr 25. Erratum in: PLoS Pathog. 2013 Aug 8;9(8):.

47.

The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia.

Hariri F, Arguello M, Volpon L, Culjkovic-Kraljacic B, Nielsen TH, Hiscott J, Mann KK, Borden KL.

Leukemia. 2013 Oct;27(10):2047-55. doi: 10.1038/leu.2013.73. Epub 2013 Mar 7.

48.

The use of oncolytic viruses to overcome lung cancer drug resistance.

Beljanski V, Hiscott J.

Curr Opin Virol. 2012 Oct;2(5):629-35. doi: 10.1016/j.coviro.2012.07.006. Epub 2012 Aug 19. Review.

PMID:
22910124
49.

HCV NS5A and IRF9 compete for CypA binding.

Bobardt M, Hopkins S, Baugh J, Chatterji U, Hernandez F, Hiscott J, Sluder A, Lin K, Gallay PA.

J Hepatol. 2013 Jan;58(1):16-23. doi: 10.1016/j.jhep.2012.08.007. Epub 2012 Aug 15.

50.

Linear ubiquitination of NEMO negatively regulates the interferon antiviral response through disruption of the MAVS-TRAF3 complex.

Belgnaoui SM, Paz S, Samuel S, Goulet ML, Sun Q, Kikkert M, Iwai K, Dikic I, Hiscott J, Lin R.

Cell Host Microbe. 2012 Aug 16;12(2):211-22. doi: 10.1016/j.chom.2012.06.009.

Supplemental Content

Loading ...
Support Center